Pedro Such, MD

H. Lundbeck A/S, Valby, Denmark

  • 5Articles
  • 47.1KReads1
  • 2002–2026Active
  • 44Collaborators
  • 123Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

Pedro Such, MD, affiliated with H. Lundbeck A/S in Valby, Denmark, has published extensively on the treatment of schizophrenia, schizoaffective disorders, bipolar disorder, and major depressive disorder. His work focuses on the safety and efficacy of antipsychotic medications, particularly aripiprazole in various formulations and dosing schedules, for maintenance therapy in bipolar I disorder and schizophrenia. He has also contributed to research on treatment discontinuation and management strategies for partial or nonresponse to antidepressant therapy. His publications span from 2002 to 2026 in peer-reviewed journals including Psychiatrist.com.

Publications

JCP
Safety and Efficacy of Maintenance Treatment with Aripiprazole Once-Monthly in Black/African American Adults With Bipolar I Disorder
Original Research

Safety and Efficacy of Maintenance Treatment with Aripiprazole Once-Monthly in Black/African American Adults With Bipolar I Disorder

March 9, 2026

The safety and efficacy of AOM 400 were comparable between Black/African American and non-Black/African American patients with bipolar I disorder
, , , et al
JCP
Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg
Original Research

Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg

September 4, 2023

A new formulation of injectable aripiprazole for administration every 2 months showed similar rates of treatment-emergent adverse events to aripiprazole once-monthly 400 mg. Patients in both groups remained clinically...
, , , et al
PCC
Original Research

Aripiprazole Once Monthly in Recent-Onset Schizophrenia

September 30, 2021

This study compared time to discontinuation and clinical outcomes of aripiprazole once-monthly 400 mg versus oral atypical antipsychotics in patients with recent-onset schizophrenia in a naturalistic setting. Read on...
, , , et al
JCP
Original Research

Aripiprazole to Treat Bipolar Disorder

March 29, 2017

Read a randomized control trial evaluating the efficacy and safety of once-monthly long-acting injectable antipsychotic aripiprazole.
, , , et al
JCP
Original Research

Partial Response and Nonresponse to Antidepressant Therapy: Current Approaches and Treatment Options

September 23, 2002

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe